Christie Administration Must Revisit Cannabis Health Benefits, NJ Court Rules

The Christie administration must reconsider its classification of cannabis as a Schedule 1 drug due to the plant’s “abundantly and glaringly apparent” medical benefits, the New Jersey appeals court has ruled.

The decision was reached in part thanks to autistic South Jersey teenager Genny Barbour, who won the right in 2015 to use cannabis at school for her seizures.

The court noted that other drugs classified as Schedule 1 – which include LSD and heroin – don’t have an “accepted medical use”, and therefore the Division of Consumer Affairs should review marijuana’s inclusion on the list.  

Such a review could pave the way for recreational cannabis legalization under New Jersey’s new governor – set to be elected next week.

The state intends to appeal the court’s decision, but that could change with a new governor.

New Jersey Governor Chris Christie is known to be an adamant opponent of cannabis, frequently touting what he views as the inevitable consequences of legalization. 

Most recently, he claimed that cannabis legalization would lead to "more death" in the United States. 

h/t Philly Voice


Though it can be hard to follow the the roller coaster ride that is keeping up with the cannabis stock market, Thomas George of Grizzle breaks it down for us simply and clearly. In the latest episode of All Time Highs, we get the lowdown on Aurora, one of the most expensive cannabis stocks, an update on Canopy's earnings, and intel on Aphria's past fraud allegations. Now in the clear, it may only be a matter of time before Aphria catches up.

Can we see some ID please?

You must be 19 years of age or older to enter.